June 21 2018, Calabasas, CA, USA
—
Calabasas, August 14, 2018:
BSMA
has appointed
Joel Glende
, an industry veteran of logistics and strategic sourcing in biopharma, to be the
Vice President of Industry Liaison for Innovation in Logistics and Transportation
. He is currently the Chairperson of the Transportation and Logistics Steering Committee to advance best practices in product protection, monitoring & adoption of disruptive technologies in Life Science Logistics.
Devendra Mishra
, Executive Director of
BSMA
, welcomed
Joel Glende,
the Founder and CEO of
Paladin Logistics Consulting
, as the Chairperson of the Steering Committee, by stating, “
Joel has had an illustrious career over 38 years serving
fortune 100 life sciences companies. His contributions in temperature control logistics, packaging engineering, operations, international customer service and company-wide strategic sourcing, are well recognized by SCM leaders. His leadership at BSMA will accelerate the realization of the goals of the Alliance.”
Joel Glende
, the appointed Chairperson of the Steering Committee, remarked, “
The exponential growth and investment in the Life Sciences such as cell therapies has opened the possibilities for the use of better tools and new technology in product protection and cloud-based logistics processes. The need for multiple sensitivity parameters in transport can provide powerful data to reduce variability avoid costly missteps and meet or exceed regulatory expectations. However, for many leading edge company executives, the risks and needs of the multimodal transportation environment are not fully understood which we will address.”
An industry panel of eminent subject matter experts will address the
11
th
Annual Conference of BSMA on October 11 in Foster City
.
As the evolution of patient therapies and the emerging product needs of Life Sciences continue to expand expectations in product commercialization, so do challenges in the Storage, Handling and Logistics of highly-sensitive Therapeutics, Pharmaceuticals and other sensitive Life Science products in global commerce. The panel and presentations will explore best practices in packaging systems and monitoring capabilities which go beyond temperature control, including such variables as shock, vibration, humidity and light exposure, and the industry mandates superior product protection throughout the Supply Chain.
Joel Glende
remarked about the proposed conference program that the
“Lack of data/visibility can derail a clinical trial and is not permissible as projects go to market. Sensitive Product Preservation and viability are not negotiable in contract terms, they’re a matter life or death for a biologic or a patient; transporting them can expose certain vulnerabilities. Many current bio-pharma and other life science packaging solutions are sub-optimal and dated. Best practices in packaging systems and emerging technology for monitoring and documenting logistics can improve critical product survivability and preserve and improve patient outcomes.”
Professionals are requested to participate and address the challenges of leveraging high end packaging, technology and data management to improve all areas of new product design, development and new product shipment needs. It is suggested that the use of Active & Passive leading edge Packaging, various Sensor capabilities, Software and integration platforms and other protective Packaging be explored by the Steering Committee formed.
